Literature DB >> 22998586

Addition of β-lactoglobulin produces water-soluble shikonin.

Alen Albreht1, Irena Vovk, Breda Simonovska.   

Abstract

Shikonin and its ester derivatives belong to a group of secondary metabolites with a wide array of beneficial effects on human health. However, shikonin is principally used in oil-based preparations due to the low solubility of the pigment in aqueous media, and the positive properties of shikonin are not exploited to their full potential. Such low aqueous solubility often results in poor bioavailability, makes shikonin undesirable for oral administration, and restricts its broadened use in the food and pharmaceutical industries. The purpose of this study was to enhance the aqueous solubility of shikonin by the addition of β-lactoglobulin and to characterize the macromolecule-ligand binding interaction by means of spectrophotometry, spectrofluorometry, high-performance liquid chromatography, and mass spectrometry. In the presence of β-lactoglobulin the solubility of shikonin is increased up to 181-fold. One shikonin molecule binds covalently to β-lactoglobulin via Cys(121), whereas the remaining pigment molecules most probably bind to the protein via noncovalent interactions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22998586     DOI: 10.1021/jf303153d

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  5 in total

1.  Combined Shikonin-Loaded MPEG-PCL Micelles Inhibits Effective Transition of Endothelial-to-Mesenchymal Cells.

Authors:  Guanglin Li; Chenxu Shang; Qingqing Li; Lifang Chen; Zejun Yue; Lingxuan Ren; Jianjun Yang; Jiye Zhang; Weirong Wang
Journal:  Int J Nanomedicine       Date:  2022-09-24

2.  Successful in vivo hyperthermal therapy toward breast cancer by Chinese medicine shikonin-loaded thermosensitive micelle.

Authors:  Yonghua Su; Nian Huang; Di Chen; Li Zhang; Xia Dong; Yun Sun; Xiandi Zhu; Fulei Zhang; Jie Gao; Ying Wang; Kexing Fan; Puichi Lo; Wei Li; Changquan Ling
Journal:  Int J Nanomedicine       Date:  2017-05-29

3.  Exploratory, Phase II Controlled Trial of Shiunko Ointment Local Application Twice a Day for 4 Weeks in Ethiopian Patients with Localized Cutaneous Leishmaniasis.

Authors:  Kesara Na-Bangchang; Oumer Ahmed; Jemal Hussein; Kenji Hirayama; Panida Kongjam; Abraham Aseffa; Juntra Karbwang
Journal:  Evid Based Complement Alternat Med       Date:  2016-04-19       Impact factor: 2.629

Review 4.  The evidence for natural therapeutics as potential anti-scarring agents in burn-related scarring.

Authors:  M Mehta; O A Branford; K J Rolfe
Journal:  Burns Trauma       Date:  2016-05-04

5.  Shikonin Suppresses NLRP3 and AIM2 Inflammasomes by Direct Inhibition of Caspase-1.

Authors:  Jernej Zorman; Petra Sušjan; Iva Hafner-Bratkovič
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.